Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients
Year: 2013
Type: article
Study design: Observational Study
Source: European Neuropsychopharmacology
Institutions: Centro de Investigación Biomédica en Red de Salud Mental, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Instituto de Salud Carlos III, Universidad de Oviedo, New York State Psychiatric Institute, Columbia University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, World Health Organization, Ministerio de Economía y Competitividad, Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología, Instituto de Salud Carlos III, European Regional Development Fund, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Cilag
Awards: G2312577913, G2994072807
OpenAlex ID: W2046557046
